Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

PURPOSE: The prognostic value of pretreatment and preoperative fibrinogen plasma levels and the modified Glasgow prognostic score (mGPS) in stage III/N2 non-small cell lung cancer (NSCLC) patients who receive neoadjuvant treatment followed by radical surgery is yet unclear. METHODS: Fibrinogen level...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinn, Katharina, Mosleh, Berta, Grusch, Michael, Klepetko, Walter, Hoetzenecker, Konrad, Klikovits, Thomas, Gompelmann, Daniela, Hoda, Mir Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675967/
https://www.ncbi.nlm.nih.gov/pubmed/36403011
http://dx.doi.org/10.1186/s12885-022-10298-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675967/
https://www.ncbi.nlm.nih.gov/pubmed/36403011
http://dx.doi.org/10.1186/s12885-022-10298-9

Ejemplares similares